Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 101–200 of 1,062
Defining human ERAD networks through an integrative mapping strategy
Christianson, J. C., Olzmann, J. A., Shaler, T. A., Sowa, M. E., Bennett, E. J., Richter, C. M., Tyler, R. E., Greenblatt, E. J., Wade Harper, J., & Kopito, R. R. (2012) · Nature Cell Biology · doi:10.1038/ncb2383 · Cited by 483
Rho GTPases, Statins, and Nitric Oxide
Rikitake, Y., & Liao, J. K. (2005) · Circulation Research · doi:10.1161/01.res.0000196564.18314.23 · Cited by 472
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
Pasanen, M. K., Neuvonen, M., Neuvonen, P. J., & Niemi, M. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230416.82349.90 · Cited by 470
Rawson, R. B., Zelenski, N. G., Nijhawan, D., Ye, J., Sakai, J., Hasan, M. T., Chang, T. Y., Brown, M. S., & Goldstein, J. L. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80006-4 · Cited by 429
Self-citationSynchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.
Keyomarsi, K., Sandoval, L. S., Band, V., & Pardee, A. B. (1991) · PubMed · Cited by 505
Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic Pathway
Edwards, P. A., & Ericsson, J. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.157 · Cited by 458
Wassmann, S., Laufs, U., Bäumer, A. T., Müller, K., Ahlbory, K., Linz, W., Itter, G., Rösen, R., Böhm, M., & Nickenig, G. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1450 · Cited by 458
Flavahan, N. A. (1992) · Circulation · doi:10.1161/01.cir.85.5.1927 · Cited by 455
Ras C-terminal processing enzymes—New drug targets?
Gibbs, J. B. (1991) · Cell · doi:10.1016/0092-8674(91)90352-y · Cited by 454
Cinnamic Acid Derivatives as Anticancer Agents-A Review
De, P., Baltas, M., & Bedos-Belval, F. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795471347 · Cited by 447
Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms
Ajikumar, P. K., Tyo, K., Carlsen, S., Mucha, O., Phon, T. H., & Stephanopoulos, G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700151b · Cited by 447
Duivenvoorden, R., Tang, J., Cormode, D. P., Mieszawska, A. J., Izquierdo-Garcia, D., Ozcan, C., Otten, M. J., Zaidi, N., Lobatto, M. E., van Rijs, S. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4065 · Cited by 442
“Statins are widely orally prescribed serum low density-lipoprotein (LDL) cholesterol-lowering drugs that upregulate LDL receptor expression in hepatocytes 8 .”
BackgroundHemmerlin, A., Hoeffler, J.-F., Meyer, O., Tritsch, D., Kagan, I. A., Grosdemange-Billiard, C., Rohmer, M., & Bach, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302526200 · Cited by 438
Rigotti, A., Miettinen, H. E., & Krieger, M. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0037 · Cited by 439
THE MEVALONATE PATHWAY AND THE SYNTHESIS OF JUVENILE HORMONE IN INSECTS
Bellés, X., Martín, D., & Piulachs, M.-D. (2005) · Annual Review of Entomology · doi:10.1146/annurev.ento.50.071803.130356 · Cited by 431
Coenzyme Q – Biosynthesis and functions
Bentinger, M., Tekle, M., & Dallner, G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.147 · Cited by 420
Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death
Garcia-Bermudez, J., Baudrier, L., Bayraktar, E. C., Shen, Y., La, K., Guarecuco, R., Yucel, B., Fiore, D., Tavora, B., Freinkman, E., et al. (2019) · Nature · doi:10.1038/s41586-019-0945-5 · Cited by 424
Statins: a repurposed drug to fight cancer
Jiang, W., Hu, J.-W., He, X.-R., Jin, W.-L., & He, X.-Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02041-2 · Cited by 417
“The mevalonate pathway is an important and complex signaling pathway for the production of various isoprenoids, such as cholesterol, vitamin D, lipoproteins, polyol and ubiquinone [136].”
BackgroundStatin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
Martin, G., Duez, H., Blanquart, C., Berezowski, V., Poulain, P., Fruchart, J.-C., Najib-Fruchart, J., Glineur, C., & Staels, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10852 · Cited by 417
“Fpp and GGpp are implicated in membrane translocation, leading to the activation of a variety of proteins, including Ras and Rho GTPbinding proteins, respectively (57, 58).”
BackgroundBustos, C., Hernández-Presa, M. A., Ortego, M., Tuñón, J., Ortega, L., Pérez, F., Díaz, C., Hernández, G., & Egido, J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00487-2 · Cited by 422
Dysregulation of the mevalonate pathway promotes transformation
Clendening, J. W., Pandyra, A., Boutros, P. C., Ghamrasni, S. E., Khosravi, F., Trentin, G. A., Martirosyan, A., Hakem, A., Hakem, R., Jurisica, I., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910258107 · Cited by 417
“Next, to address whether transcript expression of these HMGCR isoforms is regulated similarly or differently, we exploited statins as a tool to block HMGCR activity and trigger the feedback response that up-regulates its expression (9).”
InfluentialEndothelium-Dependent Effects of Statins
Wolfrum, S., Jensen, K. S., & Liao, J. K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000063385.12476.a7 · Cited by 417
Node, K., Fujita, M., Kitakaze, M., Hori, M., & Liao, J. K. (2003) · Circulation · doi:10.1161/01.cir.0000084539.58092.de · Cited by 414
Intracellular cholesterol transport
Liscum, L., & Munn, N. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00043-8 · Cited by 414
Tseng, M.-Y., Czosnyka, M., Richards, H., Pickard, J. D., & Kirkpatrick, P. J. (2005) · Stroke · doi:10.1161/01.str.0000176743.67564.5d · Cited by 415
Woods, A., Munday, M. R., Scott, J., Yang, X., Carlson, M., & Carling, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32198-1 · Cited by 403
The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases.
Friesen, J. A., & Rodwell, V. W. (2004) · Genome biology · doi:10.1186/gb-2004-5-11-248 · Cited by 474
“Degradation of HMGRH involves its transmembrane regions [14]: removal of two or more transmembrane regions abolishes the acceleration of HMGRH degradation that occurs under certain conditions [12,15]: degradation is induced by a non-sterol, mevalonate-derived metabolite alone or by a sterol plus a mevalonate-derived n…”
BackgroundSLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid
Tornio, A., Vakkilainen, J., Neuvonen, M., Backman, J. T., Neuvonen, P. J., & Niemi, M. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000148 · Cited by 409
Weber, C., Erl, W., Weber, K. S. C., & Weber, P. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00324-0 · Cited by 411
“, farnesyl or geranyl pyrophosphates—have been implicated in proteinprotein interactions and protein anchoring to lipid membranes (5,6), essentially contributing to receptor-stimulated Ca(21) increase, superoxide anion formation, low density lipoprotein (LDL) oxidation, eicosanoid synthesis and differentiation in mono…”
BackgroundSecondary metabolism in cannabis
Flores-Sanchez, I. J., & Verpoorte, R. (2008) · Phytochemistry Reviews · doi:10.1007/s11101-008-9094-4 · Cited by 400
“Studies on the isoprenoid pathway suggest that the flux of active precursors (prenyl diphosphates) can be stopped by enzymatic hydrolysis by phosphatases, activated by kinases or even redirected to other biosynthetic processes (Goldstein and Brown 1990; Meigs and Simoni 1997).”
BackgroundThe Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis
Lambert, G., Amar, M. J. A., Guo, G., Brewer, H. B., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209525200 · Cited by 392
Juvenile hormone acid methyltransferase: A key regulatory enzyme for insect metamorphosis
Shinoda, T., & Itoyama, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134232100 · Cited by 393
Gut microbiota and cardiovascular disease: opportunities and challenges
Kazemian, N., Mahmoudi, M., Halperin, F., Wu, J. C., & Pakpour, S. (2020) · Microbiome · doi:10.1186/s40168-020-00821-0 · Cited by 384
DeBose-Boyd, R. A. (2008) · Cell Research · doi:10.1038/cr.2008.61 · Cited by 391
Guijarro, C., Blanco-Colio, L. M., Ortego, M., Alonso, C., Ortiz, A., Plaza, J. J., Díaz, C., Hernández, G., & Egido, J. (1998) · Circulation Research · doi:10.1161/01.res.83.5.490 · Cited by 390
Biosynthesis and biotechnological production of ginsenosides
Kim, Y.-J., Zhang, D., & Yang, D.-C. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.03.001 · Cited by 384
“In animals, HMGR is known as the rate-limiting enzyme in cholesterol synthesis, thus HMGR is transcriptionally and post-transcriptionally regulated by multiple feedback mediated by sterol and nonsterol end-products of MVA pathway (Goldstein and Brown, 1990).”
BackgroundLaufs, U., Gertz, K., Huang, P., Nickenig, G., Böhm, M., Dirnagl, U., & Endres, M. (2000) · Stroke · doi:10.1161/01.str.31.10.2442 · Cited by 390
Laufs, U., Fata, V. L., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31725 · Cited by 387
Kikkert, M., Doolman, R., Dai, M., Avner, R., Hassink, G., van Voorden, S., Thanedar, S., Roitelman, J., Chau, V., & Wiertz, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307453200 · Cited by 384
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
Schneider, W. M., Luna, J. M., Hoffmann, H.-H., Sánchez-Rivera, F. J., Leal, A. A., Ashbrook, A. W., Le Pen, J., Ricardo-Lax, I., Michailidis, E., Peace, A., et al. (2021) · Cell · doi:10.1016/j.cell.2020.12.006 · Cited by 400
“These results suggest that factors and intermediates of the mevalonate pathway, which are known to play important roles in post-translational modification of many proteins involved in key processes, such as intracellular signaling and protein glycosylation (Buhaescu and Izzedine, 2007; Goldstein and Brown, 1990), are…”
Laufs, U., Marra, D., Node, K., & Liao, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21926 · Cited by 380
PROTEIN PRENYLATION: GENES, ENZYMES, TARGETS, AND FUNCTIONS
Schafer, W. R., & Rine, J. (1992) · Annual Review of Genetics · doi:10.1146/annurev.ge.26.120192.001233 · Cited by 377
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377
Essential Oils in Broiler Nutrition
., K.-W. L., ., H. E., & ., A. C. B. (2004) · International Journal of Poultry Science · doi:10.3923/ijps.2004.738.752 · Cited by 377
Sever, N., Yang, T., Brown, M. S., Goldstein, J. L., & DeBose-Boyd, R. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00822-5 · Cited by 372
“blocking of translation, and acceleration of protein degradation (Goldstein and Brown, 1990).”
BackgroundSelf-citationChemopreventive effect of squalene on colon cancer
Rao, C. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.287 · Cited by 373
THE MAMMALIAN LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILY
Hussain, M. M., Strickland, D. K., & Bakillah, A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.141 · Cited by 377
Song, B.-L., Sever, N., & DeBose-Boyd, R. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.009 · Cited by 328
Cholesterol metabolism: New functions and therapeutic approaches in cancer
Xu, H., Zhou, S., Tang, Q., Xia, H., & Bi, F. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188394 · Cited by 365
Statin-Associated Autoimmune Myopathy
Mammen, A. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1515161 · Cited by 366
Cali, J. J., & Russell, D. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89517-9 · Cited by 368
Ye, J., Wang, C., Sumpter, R., Brown, M. S., Goldstein, J. L., & Gale, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237238100 · Cited by 366
Self-citationHepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
Alberti, S., Schuster, G., Parini, P., Feltkamp, D., Diczfalusy, U., Rudling, M., Angelin, B., Björkhem, I., Pettersson, S., & Gustafsson, J.-′. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9794 · Cited by 367
“The biosynthesis and catabolism of cholesterol are regulated by a complex network of enzymes, which are tightly controlled by several hormones (3), by cholesterol itself (4), and possibly also by oxidized derivatives of cholesterol — the oxysterols (5).”
BackgroundResearch progress on berberine with a special focus on its oral bioavailability
Liu, C.-S., Zheng, Y.-R., Zhang, Y.-F., & Long, X.-Y. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.02.001 · Cited by 363
SNF1-related protein kinases: global regulators of carbon metabolism in plants?
Halford, N. G., & Grahame Hardie, D. (1998) · Plant Molecular Biology · doi:10.1023/a:1006024231305 · Cited by 364
A raison d’être for two distinct pathways in the early steps of plant isoprenoid biosynthesis?
Hemmerlin, A., Harwood, J. L., & Bach, T. J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.001 · Cited by 356
Waterham, H. R., Koster, J., Romeijn, G. J., Hennekam, R. C. M., Vreken, P., Andersson, H. C., FitzPatrick, D. R., Kelley, R. I., & Wanders, R. J. A. (2001) · The American Journal of Human Genetics · doi:10.1086/323473 · Cited by 356
“00 involved in a variety of cell processes, including cell growth and differentiation, glycosylation, signal transduction, and electron transport (Goldstein and Brown 1990).”
BackgroundInfluentialJeong, H. J., Lee, H.-S., Kim, K.-S., Kim, Y.-K., Yoon, D., & Park, S. W. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700443-jlr200 · Cited by 331
“nonsterol isoprenoid compounds (37, 38), the induction of PCSK9 was augmented.”
BackgroundRegulation of Inducible Nitric Oxide Synthase Gene in Glial Cells
Saha, R. N., & Pahan, K. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.929 · Cited by 353
Cholesterol Biosynthesis: A Mechanistic Overview
Cerqueira, N. M. F. S. A., Oliveira, E. F., Gesto, D. S., Santos-Martins, D., Moreira, C., Moorthy, H. N., Ramos, M. J., & Fernandes, P. A. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00342 · Cited by 352
Isoprenoids as mediators of the biological effects of statins
Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216421 · Cited by 352
“By inhibiting L-mevalonic acid synthesis, statins also prevent the synthesis of other important isoprenoid intermediates of the cholesterol biosynthetic pathway, such as farnesylpyrophosphate (FPP) and geranylgeranylpyrophosphate (GGPP) (15) (Figure 1).”
BackgroundThe Non-mevalonate Pathway of Isoprenoid Precursor Biosynthesis
Hunter, W. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700005200 · Cited by 352
Kawata, S., Yamasaki, E., Nagase, T., Inui, Y., Ito, N., Matsuda, Y., Inada, M., Tamura, S., Noda, S., Imai, Y., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1716 · Cited by 354
“Mevalonic acid, produced by HMG-CoA reductase, regulates cell growth independent of cholesterogenesis: Ras p21 and lamins A and B undergo covalent modification at the carboxyl terminus by mevalonate-derived farnesyl isoprenoid (Goldstein and Brown, 1990).”
Signal Transduction From the Endoplasmic Reticulum to the Cell Nucleus
Pahl, H. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.3.683 · Cited by 357
“Transcription of the genes encoding the LDL receptor, lipoprotein lipase, as well as cholesterol and fatty acid biosynthetic enzymes are inhibited by high intracellular sterol levels and induced upon sterol depletion (26).”
BackgroundKruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
Sen-Banerjee, S., Mir, S., Lin, Z., Hamik, A., Atkins, G. B., Das, H., Banerjee, P., Kumar, A., & Jain, M. K. (2005) · Circulation · doi:10.1161/circulationaha.104.525774 · Cited by 354
Yu, C., Wang, F., Kan, M., Jin, C., Jones, R. B., Weinstein, M., Deng, C.-X., & McKeehan, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15482 · Cited by 350
Colli, S., Eligini, S., Lalli, M., Camera, M., Paoletti, R., & Tremoli, E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.265 · Cited by 348
Schmitz, G., & Müller, G. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41642-6 · Cited by 351
Anti-inflammatory and immunomodulatory effects of statins
Blanco-Colio, L. M., Tuñón, J., Martín-Ventura, J. L., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00744.x · Cited by 347
Tocotrienol: a review of its therapeutic potential
Theriault, A., Chao, J.-T., Wang, Q., Gapor, A., & Adeli, K. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00027-2 · Cited by 346
Calcineurin is essential for survival during membrane stress in Candida albicans
Cruz, M. C., Goldstein, A. L., Blankenship, J. R., Del Poeta, M., Davis, D., Cardenas, M. E., Perfect, J. R., McCusker, J. H., & Heitman, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.546 · Cited by 342
Immune-mediated necrotizing myopathy: clinical features and pathogenesis
Allenbach, Y., Benveniste, O., Stenzel, W., & Boyer, O. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00515-9 · Cited by 335
Mo, H., & Elson, C. E. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900701 · Cited by 340
High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
Kuai, R., Li, D., Chen, Y. E., Moon, J. J., & Schwendeman, A. (2016) · ACS Nano · doi:10.1021/acsnano.5b07522 · Cited by 338
Wassmann, S., Laufs, U., Bäumer, A. T., Müller, K., Konkol, C., Sauer, H., Böhm, M., & Nickenig, G. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12257-2 · Cited by 345
Ortego, M., Bustos, C., Hernández-Presa, M. A., Tuñón, J., Dı́az, C., Hernández, G., & Egido, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00193-8 · Cited by 343
“[40] Goldstein JL, Brown MS.”
BackgroundSqualene: potential chemopreventive agent
Smith, T. J. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1841 · Cited by 337
Cholesterol: its regulation and role in central nervous system disorders
Orth, M., & Bellosta, S. (2012) · Cholesterol · doi:10.1155/2012/292598 · Cited by 339
“The first enzymes of the isoprenoid/cholesterol biosynthetic pathway, that is, the conversion of acetyl-CoA to farnesyl pyrophosphate, are localized in the cytosol except for Hmgcr which, together with most enzymes involved in cholesterol synthesis, is localized in the endoplasmatic reticulum [20, 21].”
BackgroundER protein quality control and proteasome-mediated protein degradation
Brodsky, J. L., & McCracken, A. A. (1999) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.1999.0321 · Cited by 344
Luan, Z., Chase, A. J., & Newby, A. C. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000068646.76823.ae · Cited by 341
Chappell, J., Wolf, F., Proulx, J., Cuellar, R., & Saunders, C. (1995) · Plant Physiology · doi:10.1104/pp.109.4.1337 · Cited by 335
The Effect of Statins on Mortality in Patients with Bacteremia
Liappis, A. P., Kan, V. L., Rochester, C. G., & Simon, G. L. (2001) · Clinical Infectious Diseases · doi:10.1086/323334 · Cited by 338
“3hydroxy-3-methylglutaryl–coenzyme A (HMG-CoA) reductase is the rate-limiting enzymatic step in cholesterol biosynthesis [1].”
BackgroundLu, F., Liang, Q., Abi-Mosleh, L., Das, A., De Brabander, J. K., Goldstein, J. L., & Brown, M. S. (2015) · eLife · doi:10.7554/elife.12177 · Cited by 333
“One group identified NPC1 through a haploid mutagenesis screen to detect genes required for Ebola infection in cultured cells (Carette et al., 2011).”
BackgroundSelf-citationThe potential of the mevalonate pathway for enhanced isoprenoid production
Liao, P., Hemmerlin, A., Bach, T. J., & Chye, M.-L. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.03.005 · Cited by 332
Non-lipid-related effects of statins
Bellosta, S., Fed, N., Bernini, F., Paoletti, R., & Corsini, A. (2000) · Annals of Medicine · doi:10.3109/07853890008998823 · Cited by 333
Fuhrman, B., Elis, A., & Aviram, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6520 · Cited by 324
Istvan, E. S., Palnitkar, M., Buchanan, S. K., & Deisenhofer, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.819 · Cited by 324
“HMGR is among the most highly regulated enzymes known (Goldstein and Brown, 1990).”
BackgroundThe SREBP pathway — insights from insigs and insects
Rawson, R. B. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1174 · Cited by 323
“Its carboxy-terminal domain catalyses the production of mevalonate (through one of a series of enzymatic reactions that are known as the MEVALONATE PATHWAY ), which is a substrate for isoprenoid and sterol biosynthesi”
BackgroundClarke, P. R., & Hardie, D. G. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07420.x · Cited by 317
Prostaglandins, Leukotrienes and Essential Fatty Acids
Kaur, G., Sinclair, A. J., Cameron‐Smith, D., Barr, D. P., Molero, J. C., & Konstantopoulos, N. (2009) · Cited by 321
SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast.
Hughes, A. L., Todd, B. L., & Espenshade, P. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.012 · Cited by 320
“Sre1 was recovered from wild-type cells that lack the heme A (Goldstein and Brown, 1990).”
Kim, J. B., Spotts, G. D., Halvorsen, Y.-D., Shih, H.-M., Ellenberger, T., Towle, H. C., & Spiegelman, B. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2582 · Cited by 324
“The SRE-1 sequence enhances transcription in sterol-depleted cells, and its activity is abolished when sterols accumulated ( 20 ).”
BackgroundInfluentialRegulation of gene expression by SREBP and SCAP
Edwards, P. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00140-2 · Cited by 316
Distribution and redox state of ubiquinones in rat and human tissues
Åberg, F., Appelkvist, E.-L., Dallner, G., & Ernster, L. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90511-t · Cited by 315
Wang, Z., Wu, Y., Wang, H., Zhang, Y., Mei, L., Fang, X., Zhang, X., Zhang, F., Chen, H., Liu, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319190110 · Cited by 316
“It has long been recognized that intervening with the mevalonate pathway may be useful for certain cancer treatments (44).”
BackgroundCleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis.
Wang, X., Zelenski, N. G., Yang, J., Sakai, J., Brown, M. S., & Goldstein, J. L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00438.x · Cited by 313
Self-citationSequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase.
Reiss, Y., Stradley, S. J., Gierasch, L. M., Brown, M. S., & Goldstein, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.732 · Cited by 313
Self-citationCholesterol Manipulation by West Nile Virus Perturbs the Cellular Immune Response
Mackenzie, J. M., Khromykh, A. A., & Parton, R. G. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.003 · Cited by 308
Regulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X.-W., Huang, X., Song, B.-L., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 306
“…and other products of the mevalonate pathway following statin treatment mitigates normal feedback inhibition of HMGCR in a multivalent manner (Brown and Goldstein, 1980; Goldstein and Brown, 1990), causing compensatory increases in HMGCR protein that may limit the maximal effectiveness of the drug.”
BackgroundHigh-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial
PAIVA, H., THELEN, K., COSTER, R., SMET, J., PAEPE, B., MATTILA, K., LAAKSO, J., LEHTIMAKI, T., VONBERGMANN, K., & LUTJOHANN, D. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.03.006 · Cited by 308
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.